INSMED (INSM) EBITDA: 2009-2013
Historic EBITDA for INSMED (INSM) over the last 5 years, with Dec 2013 value amounting to -$55.0 million.
- INSMED's EBITDA fell 162.30% to -$23.2 million in Q2 2014 from the same period last year, while for Jun 2014 it was -$70.0 million, marking a year-over-year decrease of 67.09%. This contributed to the annual value of -$55.0 million for FY2013, which is 29.64% down from last year.
- Per INSMED's latest filing, its EBITDA stood at -$55.0 million for FY2013, which was down 29.64% from -$42.4 million recorded in FY2012.
- INSMED's 5-year EBITDA high stood at -$8,092 for FY2010, and its period low was -$61.7 million during FY2011.
- Its 3-year average for EBITDA is -$53.1 million, with a median of -$55.0 million in 2013.
- Per our database at Business Quant, INSMED's EBITDA crashed by 762,616.26% in 2011 and then spiked by 31.24% in 2012.
- INSMED's EBITDA (Yearly) stood at -$8,674 in 2009, then rose by 6.71% to -$8,092 in 2010, then crashed by 762,616.26% to -$61.7 million in 2011, then soared by 31.24% to -$42.4 million in 2012, then fell by 29.64% to -$55.0 million in 2013.